|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Osteopontin as an ad-junct to CA125 in detecting recurrent ovarian cancer显示文摘 | Schorge JO Drake RD Lee H | 2004 | ClinCancer Res2004，10，10： | 1 |
| 2 | Osteopontin as an adjunct to CA125 in detecting recurrent ovarian cancer显示文摘 | Schorge JO Drake RD Lee H | 2004 | Clin Cancer Res2004，10，10： | 1 |
| 3 | Osteopontin as an adjunct to CA125 in detecting recurrent ovarian cancer显示文摘 | Schorge JO Drake RD Lee H | 2004 | Clin Cancer Res2004，10，10： | 1 |
| 4 | Platinum/taxane - based chemotherapy with or without radiation therapy favorably impacts survival outcomes in stage I uterine papillary serous carcinoma显示文摘 | Fader AN Drake RD O' malley DM | 2009 | Cancer2009，115，10： | 1 |
| 5 | Osteopontin as an adjunct to CA125 in detecting recurrent ovarian cancer显示文摘 | Schorge JO Drake RD Lee H | 2004 | Clin Cancer Res2004，10，10： | 1 |
| 6 | Phase I clinical trial of weekly paclitaxel, weekly carboplatin and concurrent radio- therapy for primary cervical cancer 显示文摘 | Rao GG Rogers P Drake RD | 2005 | Gynecol Oncol2005，96，1： | 1 |
| 7 | Platinum/taxane-based che-motherapy with or without radiation therapy favorably impacts survival outcomes in stage I uterine papillary serous carcinoma显示文摘 | Fader AN Drake RD Gibbons HE | 2009 | Cancer2009，115，2： | 1 |
| 8 | Phase I clinical trial of weekly paclitaxel, weekly carboplatin, and concur- rent radiotherapy for primary cervical cancer 显示文摘 | Rao GG Rogers P Drake RD | 2005 | Gynecol Oncol2005，96，1： | 1 |
| 9 | Phase I clinical trial of weekly paclitaxel,weekly carboplatin, and concurrent radiotherapy for primary cervical cancer显示文摘 | Rao OG Rogars P Drake RD | 2005 | Gynecol Oncol2005，96，1： | 1 |
| 10 | Ostecpontin as an adjunct to CA125 in detecting recurrent ovarian cancer显示文摘 | Schorge JO Drake RD Lee H | 2004 | Clin Cancer Res2004，10，10： | 1 |
| 11 | Phase I elinical trial of weekly paelitaxel, weekly carboplatin, and concurrent radiotherapy for primary cervieal cancer 显示文摘 | Rao GG Rogers P Drake RD | 2005 | Gyneeol 0neol2005，96，1： | 1 |
| 12 | Osteopontin as an adjunct to CA125 in detecting recurrent ovarican cancer显示文摘 | SCHORGE JO DRAKE RD LEE H | 2004 | Clin Cancer Res2004，10，10： | 1 |
| 13 | Osteopontin as an adjunct to CA125 in detecting recurrent ovarian cancer 显示文摘 | Schorqe JO Drake RD Lee H | 2004 | Clin Cancer Res2004，10，： | 1 |
| 14 | A phase Ⅱ evaluation of pemetrexed (Alimta, LY231514, IND #40061 ) in the treatment of recurrent or persistent endometrial carcinoma: a phase Ⅱ study of the Gynecologic Oncology 显示文摘 | Miller DS Blessing JA Drake RD | 2009 | Gynecol Oncol2009，115，3： | 1 |
| 15 | Osteopontin as an adjunct to CA125 in detecting recurrent ovarian cancer显示文摘 | Schorge JO Drake RD Lee H | 2004 | Clin Cancer Res2004，10，10： | 1 |
| 16 | Phase Ⅰ clinical trial of weekly paclitaxel, weekly carboplatin, and concurrent radiotherapy for primary cervical cancer 显示文摘 | Rao GG Rogars P Drake RD | 2005 | Gynecol Oncol2005，96，1： | 1 |
| 17 | Osteopontin as an adjunct to CA125 in detecting recurrent ovarian cancer显示文摘 | Schorge JO Drake RD Lee H | 2004 | Clin Cancer Res2004，10，10： | 1 |
| 18 | Osteopontin as an adjunct to CA 125 in detecting recurrent ovarian cancer显示文摘 | Schorge JO Drake RD Lee H | 2004 | Clin Cancer Res2004，10，10： | 1 |
| 19 | Phase I clincal trial of weekly paclitaxel,weekly carboplatin,and concurrent radiotherapy for primary cervical cancer显示文摘 | Rao GG Rogers P Drake RD | 2005 | Gynecol Oncol2005，96，1： | 1 |
| 20 | Osteopontin as an adjunct to CA125 in detecting recurrent ovarian cancer显示文摘 | Schorge JO Drake RD Lee H | 2004 | Clin Cancer Res2004，10，10： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员